A randomized controlled clinical study on the effect of mucous membrane antimicrobial agent on vaginal wound healing after hysterectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044426

Enrollment

Unknown

Registered

2021-03-18

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign diseases of uterus

Interventions

experimental group 1:mucous membrane antimicrobial agent (Mi ke le) for 7 days

experimental group 2:mucous membrane antimicrobial agent (Mi ke le) for 14 days

control group:Nil

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) In compliance with the diagnostic criteria of benign uterine lesions. (2) In compliance with the indications of total hysterectomy. (3) Preoperative blood analysis and liver and kidney function tests are normal, and no fertility requirements. (4) The patient kowns the purpose and significance of this study and is willing to sign informed consent. (5) The clinical data is complete, the compliance is good, and the patients can be followed up regularly.

Exclusion criteria

Exclusion criteria: (1) Patients with gonococcal infection. (2) Patients with allergic history and contraindications to the drugs used in this study.

Design outcomes

Primary

Measure	Time frame
healing of uterine stump;	—

Secondary

Measure	Time frame
Vaginal cleanliness;stump infection;stump bleeding;	—

Countries

China

Contacts

Public ContactWang Yu

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

renjiwangyu@126.com+86 18918358318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026